Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Macy's, Inc. (M) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Macy's, Inc. (M) - free report >>
Image: Bigstock
Top Ranked Growth Stocks to Buy for July 9th
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 9th:
ArcBest Corporation (ARCB - Free Report) : This freight transportation and integrated logistics services provider carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.
ArcBest Corporation Price and Consensus
ArcBest Corporation price-consensus-chart | ArcBest Corporation Quote
ArcBest has a PEG ratio of 0.52 compared with 1.03 for the industry. The company possesses a Growth Score of A.
ArcBest Corporation PEG Ratio (TTM)
ArcBest Corporation peg-ratio-ttm | ArcBest Corporation Quote
Equinor ASA (EQNR - Free Report) : This energy company carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.
Equinor ASA Price and Consensus
Equinor ASA price-consensus-chart | Equinor ASA Quote
Equinor has a PEG ratio of 0.17, compared with 1.08 for the industry. The company possesses a Growth Score of A.
Equinor ASA PEG Ratio (TTM)
Equinor ASA peg-ratio-ttm | Equinor ASA Quote
Macy's, Inc. (M - Free Report) : This omnichannel retail organization carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Macy's, Inc. Price and Consensus
Macy's, Inc. price-consensus-chart | Macy's, Inc. Quote
Macy's has a PEG ratio of 0.66, compared with 0.72 for the industry. The company possesses a Growth Score of B.
Macy's, Inc. PEG Ratio (TTM)
Macy's, Inc. peg-ratio-ttm | Macy's, Inc. Quote
Heritage-Crystal Clean, Inc : This parts cleaning, hazardous and non-hazardous waste, and used oil collection services provider carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.4% over the last 60 days.
Heritage-Crystal Clean, Inc. Price and Consensus
Heritage-Crystal Clean, Inc. price-consensus-chart | Heritage-Crystal Clean, Inc. Quote
Heritage-Crystal Clean has a PEG ratio of 1.25, compared with 5.12 for the industry. The company possesses a Growth Score of A.
Heritage-Crystal Clean, Inc. PEG Ratio (TTM)
Heritage-Crystal Clean, Inc. peg-ratio-ttm | Heritage-Crystal Clean, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>